S&P・Nasdaq 本質的価値 お問い合わせ

Immunovant, Inc. IMVT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$35.67
+30%

Immunovant, Inc. (IMVT) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Roivant Sciences Ltd. 113,317,007 株保有. その他の主要保有者には Health Sciences Holdings, LLC および Salzmann Peter.

過去12ヶ月間にインサイダーは 30 件の取引を実施 IMVT 株式 — 5 件の買い (評価額 $353.18M) および 21 件の売り (評価額 $937.25K). インサイダーの売りが買いを上回っています.

IMVT インサイダー保有状況

最大保有者
Roivant Sciences Ltd.
113,317,007 株
買い(12ヶ月)
5
$353.18M 評価額
売り(12ヶ月)
21
$937.25K 評価額
12ヶ月取引活動
買い 17%
売り 70%
インサイダー上位保有者
# 氏名 役職 保有株数 最終申告日 相対規模
1 Roivant Sciences Ltd. 10 Percent Owner 113,317,007 2025-12-12
100%
2 Health Sciences Holdings, Llc 10 Percent Owner 10,000,000 2019-05-15
9%
3 Salzmann Peter Chief Executive Officer 1,178,191 2025-04-17
1%
4 Wong Roderick Chief Executive Officer 902,498 2019-12-13
1%
5 Butchko Julia G. Chief Development Officer 440,959 2024-08-23
0%
6 Barnett Eva Renee Chief Financial Officer 396,774 2025-04-17
0%
7 Zeldin Robert K Chief Medical Officer 380,325 2019-12-20
0%
8 Macias William L. Chief Medical Officer 357,353 2025-02-21
0%
9 Levine Mark S. Chief Legal Officer 319,228 2024-11-22
0%
10 Geffner Michael Chief Medical Officer 217,958 2025-10-24
0%
11 Girao Tiago Chief Financial Officer 208,388 2025-05-05
0%
12 Stout Jay S Chief Technology Officer 197,634 2026-01-23
0%
13 Gloria Melanie Chief Operating Officer 170,273 2026-02-27
0%
14 Van Tuyl Christopher Chief Legal Officer 147,053 2026-03-20
0%
15 Middlekauff W Bradford General Counsel 142,600 2020-05-18
0%
16 Hughes Douglas J. Director 120,773 2025-12-03
0%
17 Jain Rita Chief Medical Officer 117,600 2021-03-31
0%
18 Elliott Michael James Chief Scientific Officer 97,600 2021-03-23
0%
19 Torti Frank Director 93,599 2025-04-03
0%
20 Fromkin Andrew J. Director 85,852 2025-12-03
0%
最近の取引 (過去12ヶ月)
日付 氏名 役職 種類 株数 株価 価値
2026-04-02 Venker Eric Chief Executive Officer 情報に基づく売り 1,409 $24.60 $34.66K
2026-04-01 Venker Eric Chief Executive Officer 株式返還 334,960 $25.10 $8.41M
2026-03-18 Van Tuyl Christopher Chief Legal Officer 情報に基づく売り 2,877 $24.97 $71.84K
2026-02-25 Gloria Melanie Chief Operating Officer 情報に基づく売り 942 $28.90 $27.22K
2026-01-21 Stout Jay S Chief Technology Officer 情報に基づく売り 1,977 $26.03 $51.46K
2026-01-07 Stout Jay S Chief Technology Officer 情報に基づく売り 55 $26.92 $1.48K
2025-12-18 Van Tuyl Christopher Chief Legal Officer 情報に基づく売り 2,284 $27.38 $62.54K
2025-12-12 Roivant Sciences Ltd. 10 Percent Owner 情報に基づく買い 16,666,666 $21.00 $350M
2025-12-01 Hughes Douglas J. Director 情報に基づく売り 1,909 $23.96 $45.74K
2025-12-01 Fromkin Andrew J. Director 情報に基づく売り 2,898 $23.95 $69.41K
2025-11-20 Gloria Melanie Chief Operating Officer 情報に基づく売り 2,375 $23.97 $56.93K
2025-10-22 Geffner Michael Chief Medical Officer 情報に基づく売り 2,595 $19.03 $49.38K
2025-10-22 Stout Jay S Chief Technology Officer 情報に基づく売り 2,520 $19.03 $47.96K
2025-10-08 Geffner Michael Chief Medical Officer 情報に基づく売り 1,272 $16.30 $20.73K
2025-10-08 Stout Jay S Chief Technology Officer 情報に基づく売り 1,585 $16.30 $25.84K
2025-07-28 Venker Eric Chief Executive Officer RSU 付与(制限付株式) 189,900 $16.76 $3.18M
2025-07-23 Geffner Michael Chief Medical Officer 情報に基づく売り 2,385 $18.15 $43.29K
2025-07-23 Stout Jay S Chief Technology Officer 情報に基づく売り 2,805 $18.15 $50.91K
2025-07-09 Geffner Michael Chief Medical Officer 情報に基づく売り 1,160 $17.24 $20K
2025-07-09 Stout Jay S Chief Technology Officer 情報に基づく売り 1,519 $17.24 $26.19K
2025-05-01 Susman Robert Graham Director RSU 付与(制限付株式) 25,016 - -
2025-05-01 Bauer Jake Director RSU 付与(制限付株式) 25,016 - -
2025-05-01 Girao Tiago Chief Financial Officer RSU 付与(制限付株式) 208,388 - -
2025-04-18 Susman Robert Graham Officer 不明 - - -
2025-04-18 Bauer Jake Officer 不明 - - -
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る